StockData
Monte Rosa Therapeutics, Inc. logo

Monte Rosa Therapeutics, Inc. (GLUE) stock

GLUENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3039% above fair value
$9.07+0.00 (0.00%)

Close on Nov 18, 2026Market cap $773.79MP/E –Yield –

Monte Rosa Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Monte Rosa Therapeutics's market cap was $878.68M on Nov 11, 2026, against $999.15M a year earlier. Over the last 5 years it ranged from $155.20M to $2.04B, with a median of $381.41M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$878.68M-9.3%
2025Dec 31, 2025$968.87M+127.5%
2024Dec 31, 2024$425.96M+50.6%
2023Dec 29, 2023$282.87M-23.2%
2022Dec 30, 2022$368.12M-61.2%
2021Dec 31, 2021$949.20M–

More Monte Rosa Therapeutics figures

See a number that looks wrong?